Attached files
file | filename |
---|---|
EX-31.2 - EX-31.2 - Allena Pharmaceuticals, Inc. | alna-ex312_6.htm |
10-K/A - 2019 FORM 10-K/A - APRIL 2020 - Allena Pharmaceuticals, Inc. | alna-10ka_20191231.htm |
Exhibit 31.1
CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Louis Brenner, M.D., certify that:
|
1. |
I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Allena Pharmaceuticals, Inc.; and |
|
2. |
Based on my knowledge, this report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: April 29, 2020 |
|
By: |
/s/ Louis Brenner |
|
|
|
Louis Brenner, M.D. |
|
|
|
Chief Executive Officer (Principal Executive Officer) |